Advances in vascular cognitive impairment

Stroke

Volumn 40, Issue 5, 2009, Pages

  Bowler, John V ^a   Gorelick, Philip B ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN[1-40]; DONEPEZIL; INSULIN; PLACEBO;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CANADA; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; HUMAN; LEUKOENCEPHALOPATHY; LONG TERM CARE; LOW DRUG DOSE; MULTIINFARCT DEMENTIA; NEUROIMAGING; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; STROKE; THALAMUS; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR COGNITIVE IMPAIRMENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; DISEASE COURSE; LEUKOARAIOSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

CEREBROVASCULAR DISORDERS; CLINICAL TRIALS AS TOPIC; COGNITION; COGNITION DISORDERS; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 65549155936     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.544650     Document Type: Short Survey

References (32)

1. Hachinski V. World Stroke Day 2008: "Little strokes, big trouble." Stroke. 2008;39:2407-2408.
2. Toncosco JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore Longitudinal Study on Aging. Ann Neurol. 2008;64:168-176.
3. Stebbins GT, Nyenhuis DL, Wang C, Cox JL, Freels S, Bangen K, DeToledo-Morrell L, Sripathirathan K, Moseley M, Turner DA, Gabrieli JDE, Gorelick PB. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008;39:785-793.
4. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol. 2008;65:642-649.
5. Brickman AM, Schupf N, Mnly JJ, Luchsinger JA, Andrews H, Tang MX, Reitz C, Small SA, Mayeux R, DeCarli C, Brown TR. Brain morphology in older African Americans, Carribean Hispanics, and Whites from Northern Manhattan. Arch Neurol. 2008;65:1053-1061.
6. Vishwanathan A, Patel P, Rahman R, Nandigan K, Kinnecom C, Bracoud L, Rosand J, Chabriat H, Greenberg SM, Smith EE. Tissue micro-structural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke. 2008;39:1988-1992.
7. Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ, Nat DR. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol. 2008;63:652-657.
8. Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71:210-216.
9. Mandell DM, Han JS, Poublanc J, Crawley AP, Kassner A, Fisher JA, Mikilis DJ. Selective reduction of blood flow to white matter during hypercapnia corresponds with leukoaraiosis. Stroke. 2008;39:1993-1998.
10. Pettersen JA, Sathiyamoorthy G, Gao F-Q, Szilgyi G, Nadkarni NK, St. George-Hyslop P, Rogaeva E, Black SE. Microbleed topography, leuko-araiosis, and cognition in probable Alzheimer disease form the Sun-nybrook Dementia Study. Arch Neurol. 2008;65:790-795.
11. Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman APA, Kappelle LJ, Mali WPTM, for the SMART Study Group. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke. 2008;39:1600-1603.
12. Virtanen JK, Siscovick DS, Longstreth WT, Kuller LH, Mozaffarian D. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology. 2008;71:439-446.
13. Ikram MA, van Oijen M, De Jong FJ, Kors JA, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Arch Neurol. 2008;39:1421-1426.
14. Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE e4. Arch Neurol. 2008;65:89-93.
15. Vidal J-S, Dufouil C, Ducros V, Tzourio C. Homocysteine, folate, and cognition in a large community-based sample of elderly people-The 3C Dijon Study. Neuroepidemiology. 2008;30:207-214.
16. van Oijen M, Okereke OI, Kang JH, Pollak MN, Hu FB, Hankinson SE, Grodstein F. Fasting insulin levels and cognitive decline in older women without diabetes. Neuroepidemiology. 2008;30:174-179.
17. Sturman MT, Mendes de Leon CF, Bienias JL, Morris MC, Wilson RS, Evans DA. Body mass index and cognitive decline in a biracial community population. Neurology. 2008;70:360-367.
18. Bombois S, Debette S, Bruandet A, Delbeuck X, Delmaire C, Leys D, Pasquier F. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke. 2008;39: 2046-2051.
19. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008;71:108-113.
20. Steffens DC, Chung H, Krishnan RR, Longstreth WT, Carlson M, Burke GL. Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly. The Cardiovascular Health Study Stroke. 2008;39:857-862.
21. Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes. J Neurol Neurosurg Psychiatry. 2008;79:869-873.
22. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG, Group ObotLS. Association of gait and balance disorders with age-related white matter changes: The LADIS study. Neurology. 2008;70:935-942.
23. Wright CB, Festa JR, Paik MC, Schmiedigen A, Brown TR, Yoshita M, DeCarli C, Sacco R, Stern Y. White matter hyperintensities and sub-clinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke. 2008;39:800-805.
24. Carey CL, Kramer JH, Josephson SA, Mungas D, Reed BR, Schuff N, Weiner MW, Chui HC. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39:397-402.
25. Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke. 2008;39:1999-2005.
26. Swartz RH, Stuss DT, Gao F, Black SE. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke. 2008;39:822-830.
27. Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A. Regional white matter pathology in mild cognitive impairment. Stroke. 2008;39:794-799.
28. Bombois S, Debette S, Delbeuck X, Bruandet A, Lepoittevin S, Delmaire C, Leys D, Pasquier F. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke. 2007;38:2595-2597.
29. Dichgans M, Markus HS, Salloway S, et al. Donepezil in paients with subcortical vascular cognitive impairment: a randomized double-blind trial in CADASIL. Lancet Neurol. 2008;7. DOI: 10.1016/S1474-4422(08)70046-2.
30. Price JF, Stewart MC, Deary IJ, Murray GD, Sandercock P, Butcher I, Fowlkes FGR on behalf of the AAAT. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ. 2008;337:a1198.
31. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymae SR, Breitner JCS, DeGroodt W, Mehta P, Craft S. Intranasal insulin improves cognition and modulates B-amyloid in early AD. Neurology. 2008;70:440-448.
32. Selnes OA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol. 2008;63:581-590.